Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Joshua Rabinowitz
Princeton University, Department: Chemistry
Should you be removed from our database? Contact us at [email protected]. Read more below.
Raze Therapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
After reviewing the information provided, I have determined that there exists a potential that your financial interest in Raze Therapeutics could directly and significantly affect the design, conduct, or reporting of your research funded by the Public Health Services. Therefore, in accordance with Federal Regulations and Princeton Policy, this is considered a financial conflict of interest (FCOI) and requires a management plan (MP) to mitigate any potential for conflict.
Metabolism in Action: Quantitative Fluxes in Mammals
Project Narrative Dysregulated metabolism underlies diabetes, obesity, and cardiovascular disease, and contributes also to other devastating diseases such as cancer and neurodegeneration. To intervene successfully in these diseases, it is critical to understand how metabolism functions and malfunctions at the whole body level. Here I propose to combine powerful modern experimental and computational technologies to revisit the overall operation of mammalian metabolism and thereby to develop knowledge and measurement methods that enable rational dietary guidance and medical intervention across a broad range of diseases.
Filed on October 22, 2018.
Tell us what you know about Joshua Rabinowitz's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Joshua Rabinowitz filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Joshua Rabinowitz | Princeton University | Conflict of Interest | Colorado Research Partners | $80,000 - $99,999 |
| Joshua Rabinowitz | Princeton University | Conflict of Interest | Kadmon Corporation | $80,000 - $99,999 |
| Joshua Rabinowitz | Princeton University | Conflict of Interest | Kadmon Pharmaceuticals | $20,000 - $39,999 |
| Joshua Rabinowitz | Princeton University | Conflict of Interest | Bantam Pharmaceuticals | $20,000 - $39,999 |
| Joshua Rabinowitz | Princeton University | Conflict of Interest | L.E.A.F. Pharmaceuticals | $10,000 - $19,999 |
| Joshua Rabinowitz | Princeton University | Conflict of Interest | Colorado Research Partners | Value cannot be readily determined |
| Joshua Rabinowitz | Princeton University | Conflict of Interest | Kadmon Pharmaceuticals | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.